What the research shows
In a human dose-response experiment, healthy adult men received intravenous hexarelin. Investigators followed growth hormone, prolactin, and cortisol in blood. Growth hormone and prolactin increased toward a plateau, while cortisol showed a different response pattern. The study demonstrates that an acute challenge can affect several hormones. Assessing long-term effects would require repeated observation and clinical endpoints. Hormone responses to intravenous hexarelin.
Documented formats
The study used a defined intravenous preparation under clinical observation. The paper also described a separate experimental condition involving growth hormone-releasing hormone. Those conditions should be kept separate when comparing results.
Testing and purity
Check for the modified D-tryptophan and the expected terminal group in the sequence record. These details distinguish hexarelin from GHRP-6 even when both are described as GH-releasing peptides.
How to read a batch reportQuestions about Hexarelin
Why did the researchers measure prolactin and cortisol too?
These measurements showed that the response extended beyond growth hormone. Looking only at the growth hormone curve would miss that part of the experiment.
What is a plateau in this study?
It is the region of the measured response curve where increasing exposure produced little further rise in the peak hormone response.